Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Biotech IncfiledCriticalJanssen Biotech Inc
Publication of MY180035ApublicationCriticalpatent/MY180035A/en
Preparation Of Compounds By Using Micro-Organisms
(AREA)
Abstract
Fully human monoclonal Abs includes (i) an antigen-binding variable region that exhibits very high binding affinity for IL-1? and (ii) a constant region that is effective at both activating the complement system though C1q binding and binding to several different Fc receptors.
MYPI2015701282A2014-05-142009-06-01Il-1? antibodies and methods of use
MY180035A
(en)